Annual Cash & Cash Equivalents
$80.93 M
-$97.34 M-54.60%
31 December 2023
Summary:
Fortress Biotech annual cash & cash equivalents is currently $80.93 million, with the most recent change of -$97.34 million (-54.60%) on 31 December 2023. During the last 3 years, it has fallen by -$152.42 million (-65.32%). FBIO annual cash & cash equivalents is now -73.53% below its all-time high of $305.74 million, reached on 31 December 2021.FBIO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$58.85 M
-$17.35 M-22.77%
30 September 2024
Summary:
Fortress Biotech quarterly cash and cash equivalents is currently $58.85 million, with the most recent change of -$17.35 million (-22.77%) on 30 September 2024. Over the past year, it has dropped by -$13.45 million (-18.61%). FBIO quarterly cash and cash equivalents is now -80.75% below its all-time high of $305.74 million, reached on 31 December 2021.FBIO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FBIO Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -54.6% | -18.6% |
| 3 y3 years | -65.3% | -76.7% |
| 5 y5 years | +23.5% | -56.4% |
FBIO Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -73.5% | at low | -80.8% | at low |
| 5 y | 5 years | -73.5% | +23.5% | -80.8% | at low |
| alltime | all time | -73.5% | +249.4% | -80.8% | +231.8% |
Fortress Biotech Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $58.85 M(-22.8%) |
| June 2024 | - | $76.20 M(-9.0%) |
| Mar 2024 | - | $83.77 M(+3.5%) |
| Dec 2023 | $80.93 M(-54.6%) | $80.93 M(+11.9%) |
| Sept 2023 | - | $72.31 M(-7.3%) |
| June 2023 | - | $78.02 M(-48.8%) |
| Mar 2023 | - | $152.48 M(-14.5%) |
| Dec 2022 | $178.27 M(-41.7%) | $178.27 M(-14.4%) |
| Sept 2022 | - | $208.35 M(-16.2%) |
| June 2022 | - | $248.77 M(-13.5%) |
| Mar 2022 | - | $287.51 M(-6.0%) |
| Dec 2021 | $305.74 M(+31.0%) | $305.74 M(+21.0%) |
| Sept 2021 | - | $252.72 M(-8.1%) |
| June 2021 | - | $274.99 M(-5.1%) |
| Mar 2021 | - | $289.90 M(+24.2%) |
| Dec 2020 | $233.35 M(+70.5%) | $233.35 M(+6.9%) |
| Sept 2020 | - | $218.39 M(+19.2%) |
| June 2020 | - | $183.28 M(+34.8%) |
| Mar 2020 | - | $135.94 M(-0.7%) |
| Dec 2019 | $136.86 M(+108.9%) | $136.86 M(+1.4%) |
| Sept 2019 | - | $134.94 M(-9.7%) |
| June 2019 | - | $149.41 M(+28.3%) |
| Mar 2019 | - | $116.44 M(+77.8%) |
| Dec 2018 | $65.51 M | $65.51 M(-31.7%) |
| Sept 2018 | - | $95.87 M(-2.8%) |
| June 2018 | - | $98.59 M(-20.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $124.02 M(+30.6%) |
| Dec 2017 | $94.95 M(+7.5%) | $94.95 M(-14.1%) |
| Sept 2017 | - | $110.54 M(-23.4%) |
| June 2017 | - | $144.34 M(+7.7%) |
| Mar 2017 | - | $134.04 M(+51.8%) |
| Dec 2016 | $88.29 M(-10.1%) | $88.29 M(+7.0%) |
| Sept 2016 | - | $82.54 M(+15.7%) |
| June 2016 | - | $71.34 M(-12.4%) |
| Mar 2016 | - | $81.42 M(-17.1%) |
| Dec 2015 | $98.18 M(+97.3%) | $98.18 M(+284.1%) |
| Sept 2015 | - | $25.56 M(-37.7%) |
| June 2015 | - | $41.04 M(-16.1%) |
| Mar 2015 | - | $48.93 M(-1.7%) |
| Dec 2014 | $49.76 M(-50.0%) | $49.76 M(-30.5%) |
| Sept 2014 | - | $71.59 M(-5.5%) |
| June 2014 | - | $75.80 M(-5.2%) |
| Mar 2014 | - | $79.98 M(-19.6%) |
| Dec 2013 | $99.52 M(+147.6%) | $99.52 M(-6.3%) |
| Sept 2013 | - | $106.27 M(+56.5%) |
| June 2013 | - | $67.89 M(+54.1%) |
| Mar 2013 | - | $44.05 M(+9.6%) |
| Dec 2012 | $40.20 M(+73.6%) | $40.20 M(-15.3%) |
| Sept 2012 | - | $47.48 M(+24.3%) |
| June 2012 | - | $38.21 M(+115.4%) |
| Mar 2012 | - | $17.73 M(-23.4%) |
| Dec 2011 | $23.16 M | $23.16 M(-13.3%) |
| Sept 2011 | - | $26.71 M |
FAQ
- What is Fortress Biotech annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Fortress Biotech?
- What is Fortress Biotech annual cash & cash equivalents year-on-year change?
- What is Fortress Biotech quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Fortress Biotech?
- What is Fortress Biotech quarterly cash and cash equivalents year-on-year change?
What is Fortress Biotech annual cash & cash equivalents?
The current annual cash & cash equivalents of FBIO is $80.93 M
What is the all time high annual cash & cash equivalents for Fortress Biotech?
Fortress Biotech all-time high annual cash & cash equivalents is $305.74 M
What is Fortress Biotech annual cash & cash equivalents year-on-year change?
Over the past year, FBIO annual cash & cash equivalents has changed by -$97.34 M (-54.60%)
What is Fortress Biotech quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of FBIO is $58.85 M
What is the all time high quarterly cash and cash equivalents for Fortress Biotech?
Fortress Biotech all-time high quarterly cash and cash equivalents is $305.74 M
What is Fortress Biotech quarterly cash and cash equivalents year-on-year change?
Over the past year, FBIO quarterly cash and cash equivalents has changed by -$13.45 M (-18.61%)